Part 11 – Page 9 – Pharma.Tips

Why Blank and System Suitability Manipulation Happens and How QA Teams Should Control It

Understanding and Controlling Blank and System Suitability Manipulation in CDS In the heavily regulated pharmaceutical industry, the integrity of data generated through chromatography is paramount. Blank and system suitability manipulation…

Inspection-Ready Approach to Peak Integration Changes in Pharmaceutical Operations

Effective Strategies for Managing Peak Integration Changes in Pharmaceutical CDS Operations In the pharmaceutical manufacturing landscape, ensuring that data integrity is maintained within chromatography data systems (CDS) is critical. One…

Uncontrolled Processing Methods: Root Causes, GMP Risks, and CAPA Controls

Addressing Uncontrolled Processing Methods: Navigating Root Causes and GMP Implications In the pharmaceutical industry, maintaining the integrity of data generated by analytical systems like chromatography data systems (CDS) is paramount.…

How to Prevent Sequence Deletion and Sample Omission in CDS (Chromatography Data System) Risks

Mitigating Risks of Sequence Deletion and Sample Omission in Chromatography Data Systems In pharmaceutical manufacturing, safeguarding data integrity is paramount, particularly within Chromatography Data Systems (CDS). One prevalent issue is…

Step-by-Step Guide to Managing Reprocessing Without Scientific Justification Under ALCOA+ Expectations

Effective Management of Reprocessing Within ALCOA+ Expectations for CDS Data Integrity In pharmaceutical manufacturing, maintaining data integrity within Chromatography Data Systems (CDS) is critical to ensure compliance and uphold product…

Why Method Version Drift Happens and How QA Teams Should Control It

Addressing Method Version Drift in Chromatography: A Guide for QA Teams The pharmaceutical industry is perpetually challenged by various data integrity risks, particularly those associated with chromatography data systems (CDS).…

Inspection-Ready Approach to Shared Administrator Accounts in Pharmaceutical Operations

Managing Data Integrity Risks Associated with Shared Administrator Accounts in Pharmaceutical Operations The increasing reliance on digital systems within pharmaceutical manufacturing has created significant challenges regarding data integrity, particularly related…

Missing Audit Trail Review: Root Causes, GMP Risks, and CAPA Controls

Addressing Missing Audit Trail Reviews in CDS: Root Causes, Risks, and Corrective Solutions In the realm of pharmaceutical manufacturing, maintaining the integrity of data is pivotal, particularly when it comes…

How to Prevent Manual Integration Abuse in CDS (Chromatography Data System) Risks

Strategies for Mitigating CDS Data Integrity Risks Due to Manual Integration Abuse Chromatography Data Systems (CDS) are crucial in ensuring the reliability of data collected during analytical procedures, especially in…

ERES and Part 11 Gaps? Practical Controls and Implementation Solutions

Addressing Gaps in ERES and Part 11 Compliance Through Practical Solutions In the pharmaceutical industry, ensuring compliance with electronic records and signatures standards such as 21 CFR Part 11 and…

Data Integrity Findings? ALCOA+ Controls and Remediation Solutions

Understanding and Remediating Data Integrity Issues in Pharmaceuticals Data integrity compliance is paramount in pharmaceutical manufacturing and quality control environments, especially given the stringent regulations enforced by agencies such as…

IT System Failures and Audit Findings? GxP IT Solutions

Addressing IT System Failures and Audit Findings in GxP Regulated Environments In pharmaceutical manufacturing, IT system failures can lead to significant operational disruptions, jeopardizing compliance with GxP regulations. When systems…